NASDAQ:IDXX IDEXX Laboratories (IDXX) Stock Price, News & Analysis $510.73 +1.17 (+0.23%) Closing price 09/15/2026 04:00 PM EasternExtended Trading$511.28 +0.56 (+0.11%) As of 06:55 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About IDEXX Laboratories Stock (NASDAQ:IDXX) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get IDEXX Laboratories alerts:Sign Up Key Stats Today's Range$502.40▼$516.0250-Day Range$504.70▼$595.7652-Week Range$500.61▼$769.98Volume603,637 shsAverage Volume459,213 shsMarket Capitalization$40.24 billionP/E Ratio35.92Dividend YieldN/APrice Target$747.00Consensus RatingModerate Buy Company Overview IDEXX Laboratories, Inc. develops and provides diagnostic, information technology and veterinary practice-management products and services. The company primarily serves the companion animal, livestock and poultry, and water testing markets, helping customers detect, monitor and manage disease. Its companion animal business includes in-house laboratory analyzers and consumables, reference laboratory services, diagnostic tests, veterinary software, digital imaging and related practice-management solutions. IDEXX also provides diagnostic products and services for livestock and poultry, as well as microbiology testing systems and services used to assess the safety and quality of water. Founded in 1983 and headquartered in Westbrook, Maine, IDEXX serves veterinary practices, commercial laboratories, public health organizations and other customers internationally. The company operates through a global network of offices, laboratories and distribution capabilities. Jay Mazelsky has served as IDEXX’s president and chief executive officer since 2022.AI Generated. May Contain Errors. Read More IDEXX Laboratories Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks84th Percentile Overall ScoreIDXX MarketRank™: IDEXX Laboratories scored higher than 84% of companies evaluated by MarketBeat, and ranked 88th out of 903 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.1 / 5Analyst RatingModerate Buy Consensus RatingIDEXX Laboratories has received a consensus rating of Moderate Buy. The company's average rating score is 2.60, and is based on no strong buy ratings, 6 buy ratings, 4 hold ratings, and no sell ratings.Upside PotentialIDEXX Laboratories has a consensus price target of $747.00, representing about 46.3% upside from its current price of $510.73.Amount of Analyst CoverageIDEXX Laboratories has only been the subject of 4 research reports in the past 90 days.Read more about IDEXX Laboratories' stock forecast and price target. Earnings and Valuation2.5 / 5Proj. Earnings Growth12.22% Earnings GrowthEarnings for IDEXX Laboratories are expected to grow by 12.22% in the coming year, from $14.81 to $16.62 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of IDEXX Laboratories is 35.92, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.87.Price to Earnings Ratio vs. SectorThe P/E ratio of IDEXX Laboratories is 35.92, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 272.90.Price to Earnings Growth RatioIDEXX Laboratories has a PEG Ratio of 2.72. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioIDEXX Laboratories has a P/B Ratio of 25.41. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about IDEXX Laboratories' valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted2.68% of the float of IDEXX Laboratories has been sold short.Short Interest Ratio / Days to CoverIDEXX Laboratories has a short interest ratio ("days to cover") of 4.35.Change versus previous monthShort interest in IDEXX Laboratories has recently increased by 7.98%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldIDEXX Laboratories does not currently pay a dividend.Dividend GrowthIDEXX Laboratories does not have a long track record of dividend growth. News and Social Media3.2 / 5News Sentiment1.06 News SentimentIDEXX Laboratories has a news sentiment score of 1.06. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.80 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 16 news articles for IDEXX Laboratories this week, compared to 5 articles on an average week.Search InterestOnly 2 people have searched for IDXX on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days.MarketBeat FollowsOnly 3 people have added IDEXX Laboratories to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership1.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, IDEXX Laboratories insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,172,172.00 in company stock.Percentage Held by Insiders0.79% of the stock of IDEXX Laboratories is held by insiders.Percentage Held by Institutions87.84% of the stock of IDEXX Laboratories is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about IDEXX Laboratories' insider trading history. Receive IDXX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for IDEXX Laboratories and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. IDXX Stock News HeadlinesIDEXX Laboratories, Inc. (IDXX) Presents at Morgan Stanley 24th Annual Global Healthcare Conference TranscriptSeptember 14 at 2:41 PM | seekingalpha.comInsider Alert: IDEXX Director Lawrence Kingsley Sells $1.2 Million of StockSeptember 10, 2026 | theglobeandmail.comA new kind of civil war is coming after election day?Across America, AI-driven backlash is fueling protests, lawsuits, and moratoria that could reshape the political and investment landscape. Whitney Tilson believes tensions may come to a head at midnight on November 4th, the day after the midterm elections, with major implications for your portfolio.September 16 at 1:00 AM | Stansberry Research (Ad)Is IDEXX Laboratories Stock Underperforming the Dow?September 10, 2026 | barchart.comIDEXX Laboratories (NASDAQ:IDXX) Director Sells $1,172,172.24 in StockSeptember 10, 2026 | insidertrades.comIDEXX Laboratories IDXX Falls to a Fresh 52-Week Low at $520.21September 9, 2026 | 247wallst.comAre Wall Street Analysts Predicting IDEXX Laboratories Stock Will Climb or Sink?August 27, 2026 | finance.yahoo.comAre Wall Street Analysts Predicting IDEXX Laboratories Stock Will Climb or Sink?August 26, 2026 | barchart.comSee More Headlines IDXX Stock Analysis - Frequently Asked Questions How have IDXX shares performed this year? IDEXX Laboratories' stock was trading at $676.53 at the start of the year. Since then, IDXX stock has decreased by 24.5% and is now trading at $510.73. How were IDEXX Laboratories' earnings last quarter? IDEXX Laboratories, Inc. (NASDAQ:IDXX) issued its quarterly earnings results on Tuesday, August, 4th. The company reported $4.27 earnings per share for the quarter, topping the consensus estimate of $3.94 by $0.33. The firm's revenue was up 9.7% compared to the same quarter last year. Read the conference call transcript. Who are IDEXX Laboratories' major shareholders? Top institutional shareholders of IDEXX Laboratories include Bank of New York Mellon Corp (1.51%), Fundsmith LLP (1.29%), UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC (1.16%) and Wellington Management Group LLP (0.92%). Insiders that own company stock include Jonathan Jay Mazelsky, Brian P Mckeon, Nimrata Hunt, Michael G Erickson, James F Polewaczyk, George Fennell, Michael Lane, Sharon E Underberg, Sophie V Vandebroek, M Anne Szostak and Bruce L Claflin. View institutional ownership trends. How do I buy shares of IDEXX Laboratories? Shares of IDXX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of IDEXX Laboratories own? Based on aggregate information from My MarketBeat watchlists, some other companies that IDEXX Laboratories investors own include Tesla (TSLA), Broadcom (AVGO), Applied Materials (AMAT), HubSpot (HUBS), ASML (ASML), CrowdStrike (CRWD) and Cadence Design Systems (CDNS). Company Calendar Last Earnings8/04/2026Today9/16/2026Next Earnings (Estimated)11/02/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (6m+) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 IDXX's financial health is in the Red zone, according to TradeSmith. IDXX has been in this zone for over 6 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:IDXX CIK874716 Webwww.idexx.com Phone(207) 556-0300Fax207-556-4346Employees11,000Year Founded1983Price Target and Rating Average Price Target for IDEXX Laboratories$747.00 High Price Target$830.00 Low Price Target$670.00 Potential Upside/Downside+46.3%Consensus RatingModerate Buy Rating Score (0-4)2.60 Research Coverage10 Analysts Profitability EPS (Trailing Twelve Months)$14.22 Trailing P/E Ratio35.92 Forward P/E Ratio34.49 P/E Growth2.72Net Income$1.06 billion Net Margins25.03% Pretax Margin31.28% Return on Equity71.96% Return on Assets33.60% Debt Debt-to-Equity Ratio0.19 Current Ratio1.17 Quick Ratio0.87 Sales & Book Value Annual Sales$4.30 billion Price / Sales9.35 Cash Flow$15.12 per share Price / Cash Flow33.78 Book Value$20.10 per share Price / Book25.41Miscellaneous Outstanding Shares78,780,000Free Float78,159,000Market Cap$40.24 billion OptionableOptionable Beta1.54 Social Links Options Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free Report This page (NASDAQ:IDXX) was last updated on 9/16/2026 by MarketBeat.com Staff. From Our PartnersThis Microcap Is Taking On the Energy Industry’s Dirtiest ProblemsA small company has developed water-based cleaning technologies aimed at some of heavy industry's toughest pro...Wall Street Logic | Sponsored“This is the Perfect Tech Stock”Jeff Brown, the tech investor who identified Nvidia in 2016 before its 37,000% run, has flagged a new AI compa...Brownstone Research | SponsoredThe national debt just passed $39 trillionThe U.S. national debt just topped $39 trillion, up nearly $3 trillion in a single year and on pace to hit $40...US Gold Bureau | SponsoredJon Najarian's #1 Energy Trade for 2026Jon Najarian says he's never been more excited about an energy opportunity. SpaceX just went public at over $2...Banyan Hill Publishing | SponsoredA “bloodbath” Is ComingReports suggest some Silicon Valley billionaires are stockpiling gold, guns, and gas masks - or leaving the co...TradeSmith | SponsoredWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredYou’ve never seen anything like this beforeFor centuries, families like the Rothschilds, Morgans, and Rockefellers have quietly used one overlooked type ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IDEXX Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IDEXX Laboratories With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
